EMJ Podcast: Insights For Healthcare Professionals

This episode, sponsored by Novartis, is a discussion around myelodysplastic syndrome (MDS). Dr Esther Natalie Oliva, Great Metropolitan Hospital BMM, Italy, and Dr David Valcárcel, Vall d'Hebron University Hospital, Spain, elucidate on data regarding immunotherapy for the treatment of patients living with MDS from the recent European School of Haematology (ESH) 7th Translational Research Conference. 

This episode, sponsored by medac, is a discussion around non-muscle-invasive bladder cancer (NMIBC). We hear from Professor Jørgen Bjerggaard Jensen, who leads clinical research in bladder cancer at the Department of Urology, Aarhus University Hospital, as he explores the management of NMIBC through the neoadjuvant use of Mitomycin C (MMC).

This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the fourth instalment in a five-part series exploring the subject of atopic dermatitis (AD). Hear from Dr Chih-Ho Hong, Dermatologist, and Dr Peter Lio, Clinical Assistant Professor, Northwestern University, Feinberg School of Medicine, who explore the roles of dupilumab versus emerging Janus kinase (JAK) inhibitor therapies in children, adolescents, and adults with moderate-to-severe AD.

This week, Jonathan reflects on the boom of the well-being industry, considering what it gets right, highlighting where it goes wrong, and offers tips on how to spot themes of pseudoscience.

This week, Jonathan sits down with Russ Bradford and Charlotte Allen, Founders, Parkinson’s Concierge, to discuss their personal experiences with the disease, the work they do to raise awareness of it, and how they feel healthcare systems could better support people living with Parkinson's.

This episode, sponsored by Novartis, features Dr Yishai Ofran, Department of Haematology and Bone Marrow Transplantation, Rambam Medical Center, Haifa, Israel, and Dr Maria Garcia-Fortes, Hospital Universitario Virgen de la Victoria, Málaga, Spain. Together, they discuss developments and data presented at the American Society of Haematology (ASH) 2020 virtual conference regarding the management of patients with acute myeloid leukaemia (AML).

This week, Jonathan sits down with Joe Capraro, Partner in the Patent and Intellectual Property Groups at Proskauer Rose LLP to decipher the elements of a patent, decode the process of protection, and decide how to choose the best lawyer.

This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the third instalment in a five-part series exploring the subject of atopic dermatitis (AD). Hear from Dr Maria Angles, Paediatric Dermatologist, Hospital Italiano of Buenos Aires, who shares the treatment results in early and sustained improvements in adolescents and adults with moderate-to-severe AD.